Insilico Medicine credits AI with a drug, but its patent names only humans
When Insilico Medicine used its computer models to propose a promising drug candidate for pulmonary fibrosis, the company enthusiastically and publicly credited the molecule as having been 'discovered by' generative AI. Its patent filing told a different story: it made no mention of AI at all and named five humans as the drug's 'inventors,' according to MIT Technology Review's Antonio Regalado. The mismatch exposes a real gap in intellectual-property law. No matter how fundamental an AI system is to a discovery, it is humans, and only humans, who can currently take credit and win legal rights to an invention. As generative AI models become able to produce drug designs almost as easily as a chatbot writes a thank-you note, working out who actually invented something is going to get harder to answer, and AI drug discovery looks set to force patent law to confront what 'inventing' even means.
The same issue of MIT Technology Review's daily newsletter, The Download, also covers Reflect Orbital, a company planning to beam sunlight from space down to Earth on demand. Later this year the company plans to launch a test satellite carrying an 18-by-18-meter mirror in orbit, with an eventual goal of launching up to 50,000 larger satellites able to reflect sunlight toward the ground whenever it is wanted. Reflect Orbital argues the technology could extend daylight for solar-panel charging, emergency response and military uses. But a new study cited in the piece, reported by Jonathan O'Callaghan, finds the giant light beams could shine as bright as 10,000 full moons and scatter light over tens of kilometers, raising concerns about dark night skies, aviation safety and wildlife.
The rest of the issue's roundup includes a report that the US data center boom is scrambling the midterm elections as politicians turn against facilities they once championed; a new study finding that 90% of biomedical papers now show signs of AI use; a stalled Ukrainian plan to send 1,000 autonomous drones a night against Moscow airports; and a feature, by Will Douglas Heaven, on researchers who study large language models the way biologists study alien organisms, to better understand their hallucinations and blind spots. The newsletter's 'quote of the day' comes from a man in a Darth Vader costume who defended the surveillance company Flock at a San Diego public safety committee meeting, telling attendees that 'the emperor is a fan of Flock.'
Key facts
- Insilico Medicine credited generative AI with discovering a pulmonary-fibrosis drug candidate but named five humans, not the AI, as inventors on the patent filing, with no mention of AI in the filing itself.
- Under current intellectual-property law, only humans can be credited as inventors and win legal rights, no matter how central an AI system was to the discovery.
- Reflect Orbital plans to launch a test satellite with an 18-by-18-meter mirror this year, working toward an eventual fleet of up to 50,000 satellites that reflect sunlight to Earth on demand.
- A new study finds the space-mirror beams could shine as bright as 10,000 full moons and scatter light over tens of kilometers, raising concerns for dark skies, aviation and wildlife.
- Elsewhere in the same newsletter issue, a study reports that 90% of biomedical papers show signs of AI use, and the US data center boom is reshaping the midterm elections.
Why it matters
Both lead stories in this issue show technology moving faster than the frameworks meant to govern it. Patent law was built around the assumption that an inventor is a person, so when a company touts an AI-discovered drug in public but still has to name humans on the legal paperwork, it exposes a category current law has no answer for. Reflect Orbital's mirrors raise a parallel problem for physical infrastructure: a company can legally launch satellites that reflect sunlight before anyone has settled how much artificial brightness the night sky, aviation routes or wildlife can tolerate.
Who it affects
Drug companies and researchers who rely on AI tools in discovery, and the patent attorneys and offices who have to process their filings, need clarity on what can legally be claimed as an invention. Reflect Orbital's plans concern astronomers, pilots and anyone near the ground track of a reflected beam, since brightness of this scale reaches well beyond the company's own operations. Both stories also matter to policymakers who will eventually have to decide whether existing rules on inventorship and orbital activity still fit.
How to use it
A company building on AI-assisted discovery should not assume that public claims about an AI 'inventing' something carry any legal weight; under current practice, a patent still needs named human inventors. Anyone tracking the space-mirror debate should watch for Reflect Orbital's test satellite launch later this year and for the brightness study's fuller findings before judging whether a 50,000-satellite fleet is workable.
How solid is it
This is MIT Technology Review's own daily newsletter, summarizing two of the outlet's reported feature stories, one on AI drug-discovery credit by Antonio Regalado and one on Reflect Orbital's space mirrors by Jonathan O'Callaghan, plus its usual roundup of links to other outlets (Axios, WSJ, Nature, Reuters) and a feature on LLM research by Will Douglas Heaven. The specific figures used here, five named inventors, the 18-by-18-meter test mirror, the 50,000-satellite goal and the 10,000-full-moons brightness estimate, come from those underlying stories.
Risks and caveats
The digest does not name or describe the five people listed as inventors on Insilico's patent, nor does it explain how patent law might actually change to accommodate AI's role, saying only that the question 'could get much harder to answer.' Reflect Orbital has not given an exact launch date for its test satellite beyond 'later this year,' and the piece does not say whether or when the full fleet of up to 50,000 satellites might be deployed. The new study behind the 10,000-full-moons brightness estimate is not dated beyond being described as 'new.'
“The emperor is a fan of Flock, and we must continue utilizing Flock technologies so that we can follow and surveil the rebel scum.”
— A man in a Darth Vader costume, defending the surveillance company Flock at a San Diego public safety committee meeting, per 404 Media